Related Experiment Video
Updated: Aug 9, 2026
09:46
Synthesis of Plant Phenol-derived Polymeric Dyes for Direct or Mordant-based Hair Dyeing
Published on: December 1, 2016
A laccase from the medicinal mushroom Ganoderma lucidum
1State Key Laboratory for Agrobiotechnology and Department of Microbiology, China Agricultural University, Beijing 100094, China.
Applied Microbiology and Biotechnology
|April 26, 2006
Summary
A novel laccase enzyme from the medicinal mushroom Ganoderma lucidum shows strong inhibitory effects against HIV-1 reverse transcriptase. This potent protein offers potential for new antiviral therapies.
Area of Science:
- Biochemistry
- Mycology
- Virology
Background:
- Medicinal mushrooms like Ganoderma lucidum are sources of bioactive compounds.
- Laccase enzymes have diverse industrial and biomedical applications.
- Human immunodeficiency virus (HIV)-1 reverse transcriptase is a key target for antiviral drug development.
Purpose of the Study:
- To isolate and characterize a novel laccase from Ganoderma lucidum.
- To evaluate the potential of this laccase as an inhibitor of HIV-1 reverse transcriptase.
Main Methods:
- Isolation of the laccase using sequential chromatography (DEAE-cellulose, Affi-gel blue gel) and Con A-Sepharose adsorption.
- Determination of molecular mass (75 kDa) and N-terminal sequencing.
- Enzyme activity assays at varying pH and temperature conditions.
- Inhibition assays against HIV-1 reverse transcriptase.
Main Results:
- A 75 kDa laccase with a unique N-terminal sequence was successfully isolated.
- The enzyme exhibited optimal activity at pH 3-5 and 70°C.
- Potent inhibitory activity against HIV-1 reverse transcriptase was observed, with an IC50 of 1.2 µM.
Conclusions:
- Ganoderma lucidum produces a novel, thermostable laccase with significant anti-HIV-1 reverse transcriptase activity.
- This mushroom-derived laccase represents a promising candidate for developing new antiviral agents against HIV.